Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system (CNS) of mammals. It plays a crucial role in regulating neuronal excitability and maintaining the balance between excitation and inhibition within neural circuits. GABA functions mainly as an inhibitory neurotransmitter, reducing neuronal excitability throughout the CNS. By binding to its receptors on neurons, GABA decreases the likelihood that these cells will fire action potentials or release other neurotransmitters, thus exerting a calming effect on brain activity. This action is essential for controlling anxiety, stress responses, motor control, mood regulation, sleep cycles, and overall behavioral modulation.
Benzodiazepines enhance GABAA receptor-mediated transmission for anxiolytic/sedative effects. Barbiturates also potentiate this pathway.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on γ-Aminobutyric acid (GABA).